Ruximla Trademark Details
Word Mark | Ruximla |
---|---|
Status | Dead 606 — Abandoned - No Statement of Use Filed |
Pfizer Inc.
235 East 42nd Street
New York, Ny 10017
235 East 42nd Street
New York, Ny 10017
Pfizer Inc.
235 East 42nd Street
New York, Ny 10017
235 East 42nd Street
New York, Ny 10017
Serial Number | 86692265 |
---|---|
Status Date | Monday, August 22, 2016 |
Filing Date | Monday, August 22, 2016 |
Attorney | Katrina Edge |
Correspondent
KATRINA EDGE
Pfizer Inc
235 E 42nd St
New York, NY 10017-5703
Pfizer Inc
235 E 42nd St
New York, NY 10017-5703
Case File Statements
Goods & Services | Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use |
---|
Classifications
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Friday, July 17, 2015 |
Primary Code | 005 |
Trademark Timeline
-
Jul 14 2015Trademark application filed with USPTO
-
Jul 17 2015New Application Office Supplied Data Entered In Tram
-
Jul 17 2015New Application Entered In Tram
-
Oct 15 2015Assigned To Examiner
-
Oct 16 2015Approved For Pub - Principal Register
-
Nov 04 2015Notification of Notice of Publication E-Mailed
-
Nov 24 2015Official Gazette Publication Confirmation E-Mailed
-
Nov 24 2015Published For Opposition
-
Jan 19 2016Noa E-Mailed - Sou Required From Applicant
-
Aug 22 2016Abandonment Notice Mailed - No Use Statement Filed
-
Aug 22 2016Abandonment - No Use Statement Filed